Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
101.10
86.31
23.44
49.17
11.75
39.66
10.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
101.10
86.31
23.44
49.17
11.75
39.66
10.12
Raw Material Cost
0.00
0.15
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
57.81
11.20
7.58
34.72
2.18
40.86
17.52
(Increase) / Decrease In Stocks
-8.92
1.34
4.96
4.59
5.36
-4.74
-8.90
Employee Cost
4.17
3.75
3.16
0.94
0.75
0.51
0.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.28
48.95
0.22
0.00
0.00
0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
25.19
4.66
3.26
6.42
2.96
2.52
1.29
Total Expenditure (Excl Depreciation)
79.53
70.05
19.18
46.67
11.25
39.16
10.29
Operating Profit (PBDIT) excl Other Income
21.57
16.26
4.26
2.50
0.50
0.50
-0.17
Other Income
1.09
2.48
7.47
0.15
0.38
0.22
0.74
Operating Profit (PBDIT)
22.66
18.74
11.73
2.65
0.88
0.72
0.57
Interest
0.64
0.92
0.67
0.23
0.07
0.05
0.13
Exceptional Items
0.00
0.00
-0.11
-0.09
0.00
-0.17
-0.05
Gross Profit (PBDT)
22.02
17.82
10.95
2.33
0.81
0.50
0.39
Depreciation
0.77
0.51
0.77
0.51
0.56
0.29
0.28
Profit Before Tax
21.19
17.26
10.18
1.81
0.12
0.21
0.08
Tax
1.95
3.37
5.17
0.50
0.42
-0.08
0.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.29
13.94
5.01
1.33
-0.16
0.29
-0.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.29
13.94
5.01
1.33
-0.16
0.29
-0.08
Share in Profit of Associates
-0.06
-0.04
0.00
-0.02
-0.13
0.00
-0.04
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.23
13.90
5.01
1.31
-0.29
0.29
-0.12
Equity Capital
64.85
64.85
53.50
53.50
53.50
53.50
53.50
Face Value
1.0
1.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.3
0.21
0.09
0.02
-0.01
0.01
-0.02
Diluted Earnings per share
0.29
0.21
0.08
-0.01
-0.01
0.01
0.64
Operating Profit Margin (Excl OI)
21.34%
18.84%
18.17%
5.08%
4.26%
1.26%
-1.68%
Gross Profit Margin
21.78%
20.65%
46.72%
4.74%
6.89%
1.26%
3.85%
PAT Margin
19.02%
16.1%
21.37%
2.66%
-2.47%
0.73%
-1.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -82.23% vs 63.66% in Sep 2025
Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is -298.81% vs 237.70% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -214.91% vs 208.11% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is -14.29% vs -14.50% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Fischer Medical With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
101.10
0
101.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
101.10
0
101.10
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
57.81
0
57.81
(Increase) / Decrease In Stocks
-8.92
0
-8.92
Employee Cost
4.17
0
4.17
Power Cost
0.00
0
0.00
Manufacturing Expenses
1.28
0
1.28
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
25.19
0.00
25.19
Total Expenditure (Excl Depreciation)
79.53
0
79.53
Operating Profit (PBDIT) excl Other Income
21.57
0.00
21.57
Other Income
1.09
0
1.09
Operating Profit (PBDIT)
22.66
0
22.66
Interest
0.64
0
0.64
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
22.02
0
22.02
Depreciation
0.77
0
0.77
Profit Before Tax
21.19
0
21.19
Tax
1.95
0
1.95
Provisions and contingencies
0.00
0
0.00
Profit After Tax
19.29
0
19.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
19.29
0
19.29
Share in Profit of Associates
-0.06
0
-0.06
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.23
0
19.23
Equity Capital
64.85
0
64.85
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
21.34%
0%
0.00
21.34%
Gross Profit Margin
21.78%
0%
0.00
21.78%
PAT Margin
19.02%
0%
0.00
19.02%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.32 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -82.23% vs 63.66% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Quarterly - Standalone Net Profit
Standalone Net Profit -1.67 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -298.81% vs 237.70% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -935.00% vs 253.85% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.31 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -214.91% vs 208.11% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -495.45% vs -83.33% in Dec 2024
Quarterly - Interest
Interest 0.96 Cr
in Dec 2025Figures in Cr
QoQ Growth in quarter ended Dec 2025 is -14.29% vs -14.50% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -99.24%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
